Alexander Bystritsky, MD

Semel Institute for Neuroscience and Human Behavior, University of California Los Angeles, Los Angeles, California

  • 12Articles
  • 36.6KReads
  • 1997–2025Active
  • 62Collaborators
  • 546Citations

About

Alexander Bystritsky, MD is affiliated with Semel Institute for Neuroscience and Human Behavior, University of California Los Angeles, Los Angeles, California. Alexander Bystritsky has authored or co-authored 12 peer-reviewed articles published across the Journal of Clinical Psychiatry and the Primary Care Companion for CNS Disorders between 1997 and 2025. Their work focuses on Anxiety, Obsessive-Compulsive and Related Disorders, Anxiolytics, Depression (MDD), and Panic Disorder.

Publications

JCP
Effect of Aripiprazole or rTMS Augmentation Versus Switching to Venlafaxine on Quality of Life
Original Research

Effect of Aripiprazole or rTMS Augmentation Versus Switching to Venlafaxine on Quality of Life

August 11, 2025

Augmentation with aripiprazole, but not rTMS, improved quality of life significantly versus venlafaxine XR/duloxetine switch in patients with treatment-resistant depression.
, , , et al
JCP
Original Research

Effects of Co-Occurring Depression on Treatment for Anxiety Disorders: Analysis of Outcomes From a Large Primary Care Effectiveness Trial

December 15, 2012

, , , et al
JCP
Original Research

Quality of and Patient Satisfaction With Primary Health Care for Anxiety Disorders

February 22, 2011

, , , et al
JCP
Letter to the Editor

A Preliminary Study of fMRI-Guided rTMS in the Treatment of Generalized Anxiety Disorder: 6-Month Follow-Up

May 15, 2009

, ,
JCP
Original Research

A Preliminary Study of fMRI-Guided rTMS in the Treatment of Generalized Anxiety Disorder

July 31, 2008

, , , et al
JCP
Original Research

A Pilot Study of Cranial Electrotherapy Stimulation for Generalized Anxiety Disorder

March 14, 2008

, ,
JCP
Original Research

Quetiapine Augmentation in Obsessive-Compulsive Disorder Resistant to Serotonin Reuptake Inhibitors: An Open-Label Study

January 15, 2005

, , , et al
JCP
Original Research

Augmentation of Serotonin Reuptake Inhibitors in Refractory Obsessive-Compulsive Disorder Using Adjunctive Olanzapine: A Placebo-Controlled Trial

April 1, 2004

, , , et al
JCP
Original Research

Obsessive-Compulsive Hoarding: Symptom Severity and Response to Multimodal Treatment

January 1, 2002

, , , et al
JCP
Article

Panic Disorder in the Primary Care Setting: Comorbidity, Disability, Service Utilization, and Treatment

July 1, 1999

, , , et al
JCP
Letter to the Editor

Reply to Letter to the Editor "Risperidone May Worsen Fluoxetine-Treated OCD"

May 15, 1998

,
JCP
Article

Double-Blind, Placebo-Controlled Trial of Two Doses of Abecarnil for Geriatric Anxiety

May 1, 1997

,

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe